How Serum Institute is using GS1 Standards for COVID vaccine traceability
The Executive Director of the Serum Institute of India discusses how they are using GS1 standards to ensure the traceability and authenticity of COVID-19 vaccines
Body
Dr. Sunil Gairola, Executive Director of the Serum Institute of India discusses how the Serum Institute of India is using GS1 standards to ensure the traceability and authenticity of COVID-19 vaccines. The implementation of these standards has allowed for greater transparency in the supply chain, improved vaccine quality control, and increased patient safety.